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Abstract
Prp19 is an essential splicing factor and a member of the U-box family of E3 ubiquitin ligases. Prp19
forms a tetramer via a central coiled-coil domain. Here we show the U-box domain of Prp19 exists
as a dimer within the context of the Prp19 tetramer. A high-resolution structure of the homo-dimeric
state of the Prp19 U-box was determined by x-ray crystallography. Mutation of the U-box dimer
interface abrogates U-box dimer formation and is lethal in vivo. The structure of the U-box dimer
enables construction of a complete model of Prp19 providing insights into how the tetrameric protein
functions as an E3 ligase. Finally, comparison of the Prp19 U-box homodimer with the heterodimeric
complex of BRCA1/BARD1 RING-finger domains uncovers a common architecture for a family of
oligmeric U-box and RING-finger E3 ubiquitin ligases, which has mechanistic implications for E3
ligase mediated poly-ubiquitination and E4 poly-ubiquitin ligases.
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Post-translational modification of target proteins via covalent attachment of ubiquitin and
ubiquitin-like modifiers (ubl) is a central regulatory mechanism utilized in many different
cellular pathways (1,2). The most extensively studied mechanism of ubiquitin mediated
signaling involves poly-ubiquination of substrate proteins leading to target degradation by the
26S proteosome (3,4). However, the addition of either one or a few ubiquitin molecules has
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been shown to mediate protein activity, protein-protein interactions, and sub-cellular
localization (5-7).
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Addition of ubiquitin is accomplished via a conserved enzyme cascade consisting of activating
(E1), conjugating (E2), and ligating (E3) enzymes (8-10). There is generally one activating E1
and approximately twenty conjugating E2's. These are complemented by hundreds of E3
ligases, which provide the essential substrate selectivity for modulation of the specific signaling
pathways (10). Similar cascades (E1, E2, E3) exist for the different ubl pathways such as
SUMO, Nedd8/Rub1, and Hub1.
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U-box, RING-finger, and HECT-domain containing proteins represent three families of E3
ubiquitin ligases. RING-finger and U-box E3s facilitate the transfer of Ub by precise spatial
orientation of the E2 and the substrate rather than binding Ub directly as seen in the HECT
family (11). The U-box or RING-finger domain serves as the E2 recruitment domain while
another distinct domain, such as leucine rich repeats or WD40 repeats, serve to recognize and
recruit the substrate. RING-finger proteins represent the largest family of E3 ubiquitin ligases.
Their structure is characterized by eight conserved zinc-chelating residues that bind two zinc
atoms in a cross-braced orientation (12,13). U-box domain proteins are the most recently
identified family of E3 ligases (14-18). Although the U-box domain is structurally homologous
to the RING-finger domain, it lacks the eight canonical zinc chelating residues found in the
RING-finger (14,19). Instead, the U-box is stabilized through two centers composed of
hydrogen bonds and salt bridges (19,20). Despite this difference, RING-finger and U-box
domains share a shallow hydrophobic groove that directly interacts with the E2 (9,19).
E3 ubiqutin ligases fall into two basic categories: either simple or complex. Simple ligases are
composed of a single polypeptide that contains either a RING-finger or U-box domain to recruit
the E2 and an additional domain(s), such as WD40 repeats, to interact with a substrate. Complex
ligases are either multi-protein or multi-copy complexes, both of which require complex
quaternary structure to function. Some multi-protein complex ligases, such as the SCF and
anaphase promoting complex (APC) ubiquitin ligases, are large assemblies of different proteins
that together contain only a single E2 recruitment domain and a single substrate recognition
domain. Other complex ligases are oligomeric and thus contain multiple E2 recruitment and/
or substrate recognition domains. Indeed, numerous RING-finger and U-box containing E3
ubiquitin ligases are known to form higher order homo- and hetero-oligomeric species.
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The oligomerization of E3 ligases is often mediated by a known oligomerization domain such
as a coiled-coil or helical bundle; however, there are also a number of examples where the
RING-finger domain itself is known to contribute to the oligomeric interface (21,22). While
there are only a limited number of structural studies characterizing dimerization of RINGfinger and U-box domains, biochemical characterization has revealed that many E3 ligases
form specific homo and hetero-dimeric species that are mediated by direct RING/RING, RING/
U-box, and U-box/U-box interactions (22-25). Further, a prototypical plant U-box, AtPUB14,
has been shown to form U-box mediated dimers of uncharacterized structure (20). While the
importance of homo- and hetero-dimeric complexes in ubiquitin ligase signaling is clear, it
remains to be determined whether the dimer interfaces between RING-finger and U-box
domains are conserved and whether a general mechanism(s) for dimerization exists.
This study provides the first structure of a U-box domain dimer. Combined with previous data,
this structure enables the construction of a model of the full length Prp19 homotetramer. In
addition, detailed analysis of this structure combined with previous biochemical analyses
strongly implies the existence of a common mode of dimerization for certain U-box and RINGfinger domains.
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Materials and Methods
Protein expression and purification
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S. cerevisiae Prp19 constructs were expressed in E. coli as a 6xHIS tag fusion protein from
pET15b. Protein was produced and purified using established protocols for Prp19(1-73) (19).
Briefly, proteins were expressed using BL21(DE3) cells (Novagen) in Luria-Broth (LB). For
seleno-methionine labeled protein, protein was expressed using 834(DE3) cells (Novagen) in
M9 minimal media supplemented with seleno-methionine. Proteins were purified using a
Ni2+-nitrilotriacetic acid column (Qiagen) with an imidazole gradient from 25-500 mM. The
6xHIS-tag was cleaved by incubation with thrombin (1 U/1 mg protein) for 12 h at 4°C for Ubox constructs and 36 h at 4°C for Prp19(1-133). Protein was then purified using anion
exchange over a MonoQ column (Amersham-Pharmacia) with a gradient of NaCl from 10-500
mM.
Strains and media
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S. cerevisiae strains used in this study were grown either in synthetic minimal medium with
the appropriate nutritional supplements or yeast extract-peptone-extrose (26). Transformations
were performed by the lithium acetate method (27). Haploid strain containing a temperaturesensitive copy of PRP19 (prp19-1) (KGY1811) transformed with pRS415 plasmids containing
either wild-type PRP19 or prp19-L15E. The ability of prp19-L15E to rescue growth at the
restrictive temperature was scored by spotting serial dilutions and incubating them at
permissive (25°C) or restrictive (36°C) temperature for 3 days. prp19::HIS3 ura3-52 leu2Δ1 haploid strain carrying a URA3-selectable vector expressing wild-type PRP19 transformed
with either PRP19 cDNA or prp19-L15E under control of the GAL1 promoter in a LEU2-based
vector. Ura+ Leu+ transformants were serially diluted on plates containing or not 5-flourootic
acid and uracil to score the ability of prp19-L15 to rescue growth of the prp19Δ strain after 3
days.
Analytical ultracentrifugation
Sedimentation velocity experiments were conducted with an Optima XLA (Beckman-Coulter,
Fullerton, CA), with a 4-hole An60Ti rotor using double sector cells with charcoal-filled Epon
centerpieces (pathlength 1.2 cm) and quartz windows. The experiments were conducted at 25°
C at a speed of 40,000 rpm and concentration profiles measured at 280 nm. The velocity scans
were analyzed with the program Sedfit (version 8.7) (28) using 300 scans collected
approximately 2 minutes apart. Size distributions were determined for a confidence level of
p = 0.95, a resolution of n = 300 and sedimentation coefficients between 0.1 and 20 s.
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Crystallization
Crystals of the U-box domain, Prp19(1-58), were prepared in hanging-drop vapor-diffusion
experiments with a 1:1 mixture of protein at 15 mgs/ml and 33% Poly-Ethylene Glycol (PEG)
4000, 75 mM MgCl2, 0.1 M Tris pH 8.5, 1 mM DTT at 4°C. Seleno-methionine labeled protein
crystals were obtained in 38% PEG 4000, 75 mM MgCl2, 0.1 M Tris pH 8.5, 1 mM DTT at
4°C. Prior to data collection, crystals were serially transferred to mother liquor containing 5,
10, 15% ethylene glycol and flash frozen. Diffraction data statistics are summarized in Table
I.
Crystal structure determination
Data were collected at the Center for Advanced Microstructures and Devices (CAMD) using
beamline PX. Selenomethionine MAD data were collected to 2.5 Å with wavelength selection
based on a fluorescence energy scan. The data were processed using DENZO/SCALEPACK
(29). SOLVE was used to locate all six (one per subunit) expected selenium sites (30). Native
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crystals of the Prp19 U-box dimer diffracted to 1.5 Å. Phase extension and initial model
building was accomplished using RESOLVE (31). No averaging of the multiple subunits in
the asymmetric unit was employed during refinement. Additional model building and
refinement was accomplished using XtalView (32) and Refmac5 (33). Final refinement
statistics are summarized in Table 1. The atomic coordinates and structure factors have been
deposited in the PDB (PDB ID code 2BAY).
Dimer interfaces were analyzed using the Protein-Protein interaction server
(http://www.biochem.ucl.ac.uk/bsm/PP/server/).

Results
Oligomerization state of the Prp19 U-box
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The U-box containing protein Prp19 contains three recognized domains: an N-terminal U-box,
a central coiled-coil, and a C-terminal WD40 repeat β-propeller domain (Figure 1A). Recently,
we demonstrated using electron microscopy and analytical ultra-centrifugation that Prp19
exists as a tetramer, with the coiled-coil domain serving as the primary oligomerization domain
(34). The EM studies also revealed that, in the absence of additional binding partners the Prp19
WD40 repeat domains are flexibly tethered to the tetrameric core of the molecule (34). The Ubox domain was not directly detectible by EM due to its small size. Thus, the status of the Ubox domain in the context of the Prp19 tetramer remained unclear.
To obtain insight into the structure of the U-box within the context of the Prp19 tetramer, a
construct was characterized, Prp19(1-133), which contains both the N-terminal U-box and
central coiled-coil domain. The oligomerization state of this construct was determined by
analytical ultracentrifugation. The major peak (75%) exhibited a sedimentation value (s) of 2.7
with a frictional ratio of 1.9. This is consistent with a tetrameric state of 66kDa (Figure 1B)
and reaffirms our previous finding that the coiled-coil domain is both necessary and sufficient
for Prp19 tetramerization (34). In addition to the tetramer, a small amount of monomer (<10%,
s=1.1) as well as higher order species (∼15%) were detected in the analytical ultracentrifugation
analysis (Figure 1B). The frictional ratio indicates an elongated molecule, consistent with the
presence of an extended coiled coil domain linked to the globular U-box (34).
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CD and NMR spectroscopy were then used to characterize the secondary and tertiary structure
of Prp19(1-133), as compared to the intact Prp19 tetramer and the isolated U-box. The minima
in the CD spectrum at 208 and 222 nm indicate Prp19(1-133) is a well folded protein with
mainly helical secondary structure (Figure 1C), as expected based on the previous U-box
structure and the predicted coiled-coil region. Analysis of the 15N-1H HSQC NMR spectrum
of Prp19(1-133) reveals extensive line broadening with only a few broad resonances
discernable (Figure 1D), which is nearly identical to the spectrum of the intact Prp19 tetramer.
This result is insightful because it strongly implies that in the context of the tetrameric coiledcoil domain, the U-box domains do not exist as flexibly tethered independent domains, but
rather, Prp19(1-133) tumbles as a single unit. If the U-box domains were flexibly tethered to
the core coiled-coil tetramer, narrow signals would be observed in the NMR spectrum
corresponding closely to those of the isolated U-box domain, as has been seen for example in
the small independent RPA32C domain of the ∼50 kDa RPA14/32 complex and the C-terminal
domains of the L7/L12 stalk proteins in the intact ribosome (35, 36).
To obtain deeper insight into the state of the U-box in the context of the Prp19 tetramer, we
used analytical ultracentrifugation to examine the propensity of the isolated U-box domain to
self-associate. This analysis shows that the Prp19 U-box exists in equilibrium between two
states, which are assigned to a monomer (s=1.4) and a dimer (s=2.1) in a ratio of 7:3 (Figure
1E) with a frictional ratio of 1.3. Thus, although weak, the U-box does have an intrinsic
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propensity to dimerize. Importantly, we have observed that the equilibrium is shifted towards
the dimer by increasing ionic strength and protein concentration. These results have
implications for the U-box, indicating that the prosperity to dimerize will be enhanced
significantly in the context of intact Prp19 due to the close spatial proximity of pairs of Uboxes on either side of the tetramer (Fig 1F). This can be understood by considering that
tethering of the U-box via a short (∼10 residue) linker to the tetrameric coiled-coil domain
results in a very high local concentration of U-boxes, which shifts the monomer-dimer
equilibrium strongly towards the dimeric state.
To summarize, the EM, AU, CD and NMR data, taken together, strongly support our contention
that the Prp19 U-box exists in a dimeric state in the context of intact Prp19. This conclusion
is fully consistent with previous yeast two hybrid evidence that the U-box domain of Prp19 is
involved in protein self-association (37).
Crystal structure of the Prp19 U-box dimer
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With the objective of producing crystals of the dimeric state of the Prp19 U-box, crystallization
trials were set up with a relatively high protein concentration of 15 mg/mL. Crystals were
obtained in a relatively rapid manner which diffracted to high resolution. Initial phases were
derived from MAD (multi-wavelength anomalous diffraction) experiments using SeMetsubstituted protein and the structure was determined to 1.5 Å, with three dimers in the
asymmetric unit (Table I, Figure 2A). The U-box domain adopts the typical U-box fold and
all copies in the asymmetric unit are superimposable with a backbone r.m.s.d. of 0.28 Å (19,
20). The dimer subunits overlay well with the previously reported NMR structure of the Prp19
U-box in the monomeric state (backbone r.m.s.d. of 0.94 Å), with all significant differences
between the crystal and solution structures at the dimer interface. The major structural
difference between the structure of the monomer and the dimer is in the conformation of a loop
region immediately adjacent to the third β-strand (residues 53-57), which is involved in critical
intermolecular contacts (Figure 2A).
The dimer interface of the Prp19 U-box is formed by residues contributed from the N-terminal
loop and the three β-strands. The overall buried surface area is 695 Å2/subunit with a 69%
hydrophobic and 31% hydrophilic character, and a high degree of shape complimentarity
(Sc=0.75) (38). The hydrophobic character of the dimer interface is due to residues Leu15,
Ile22, Val51, and Ile53 (Figure 2B, C). Importantly, all four positions are conserved long chain
hydrophobics (Val, Ile, Leu) in Prp19 from yeast to man.
Functional analysis of the Prp19 U-box dimer
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In order to assess the role of U-box dimerization in Prp19 function, mutations were made to
the residues identified at the dimer interface (Figure 2A), including L15, V51, and I53. In order
to select the best candidate for the more complex biological assays, biophysical analyses of
these mutations were performed first to determine how effective these mutations were at
disrupting the ability of the Prp19 U-box to self associate. Not unexpectedly, the most
significant effect was from mutation of leucine 15, the hydrophobic residue at the center of the
dimer interface. Analytical ultra-centrifugation analysis of the L15E mutant provided a single
peak with an s value of 1.4; indicating it exists exclusively in a monomeric state. The frictional
ratio of 1.3 is similar to that observed for the peak of the wild-type monomer. Thus, there is
no evidence of the monomer-dimer equilibrium seen for the wild-type protein (Figure 2D, cf.
Figure 1E). To ensure that the mutant protein adopts a stable, native-like fold an 15N-1H HSQC
spectrum was acquired for the L15E U-box construct (Figure 2E). The spectrum of the mutant
was found to be nearly identical to that of the wild-type U-box, indicating that the structure
was not perturbed by the mutation. Consequently, the L15E mutant was selected for analysis
of the effect on Prp19 biological activity arising from destabilizing U-box dimerization.
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Prp19 is an essential protein, and thus required for viability. Consequently, the functional
significance of Prp19 mutations could be determined in vivo by introducing the L15E mutation
into the full-length protein. Two complimentary approaches were were utilized. The first
involved assessing the ability of the mutant protein to complement the prp19 temperature
sensitive allele, prp19-1, at the restrictive temperature (Figure 2F, upper panels). The second
approach involved complementation of the null allele of prp19 by a conventional plasmid
shuffle approach (Figure 2F, lower panels). The results for L15E in both assays revealed that
this single mutation, which disrupts U-box dimerization, is sufficient to compromise cell
viability. The origin of this effect is presumably through disruption of the ligase activity of
Prp19, or perhaps through destabilization of the NTC complex as observed for the Prp19-1
mutation (19). Taken together, the physical and functional effects of dimer interface mutations
underscore the physiological relevance of the Prp19 U-box dimer and imply that dimerization
of the Prp19 U-box is necessary for its function in vivo.
Stabilization centers in the U-box domain
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As already noted, the binding of two zinc atoms are essential for the stability of the RINGfinger domains. The high-resolution crystal structure of the Prp19 U-box provides the first
detailed view of the series of hydrogen bonds and salt bridges that serve to stabilize the U-box
fold in place of the essential zinc atoms in the RING-finger domains (19). Both protein
functional groups and tightly bound water molecules are observed in the U-box networks
(Figure 3A). Several useful insights have been obtained by comparing to the corresponding
zinc-mediated stabilization centers in the crystal structure of the Rag1 RING-finger (Figure
3B) (39).
The C-terminal stabilization center in the U-box domain involves four core residues (Ser16,
Ser19, Asp38, Thr41) with the non-conserved Glu43 peripherally involved (Figure 3C). There
are no detectable solvent molecules in this network. The overall arrangement is very similar
to that of the corresponding zinc-mediated stabilization center seen in RING-finger domains
(Figure 3D). In the case of Prp19, Asp38 appears to be central to the interaction network and
closely mimics the zinc atom at the center of the RING-finger stabilization center.
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A much different picture emerges for the N-terminal stabilization center of the Prp19 U-box,
which includes five core residues (Cys3, Ser6, Arg12, Glu24, Ser26) and two high occupancy
water molecules (Figure 3E). The backbone trace of this region of Prp19 is virtually
superimposable on the RING-finger domain of Rag1 (Figure 3E, 3F). Despite the remarkable
similarity of the backbone conformation, the U-box center differs markedly from that of a
RING-finger (Figure 3F). In particular, the residues involved in stabilizing the U-box are more
widely distributed than the four zinc chelating residues in the RING finger domain and many
more side-chain to backbone amide hydrogen-bonds are apparent. In addition, the U-box center
includes high occupancy solvent molecules, something that is not found in the RING-finger
structure.
Interestingly, Cys3 and Ser6 in Prp19 are structurally homologous to two of the RING-finger
zinc chelating ligands. Although there is no U-box atom that directly corresponds to the RINGfinger zinc atom, Glu-24 is located near the center of the extended stabilization site and makes
contacts with both solvent molecules and Ser26. The latter is located one residue shifted from
the corresponding zinc chelating residue in the RING finger domain. This positional shift
appears to result in an expansion of the U-box center and the inclusion of the tightly bound
water and Arg12. While static pictures of the stabilization centers provide significant insight,
analysis of conformational variability within individual molecules and between the different
copies in the unit cell reveal these inter-residue interactions are dynamic. For example,
differences in the side-chain conformations of Arg12, Glu24, and Ser26 are evident when
comparing different molecules in the asymmetric unit.
Biochemistry. Author manuscript; available in PMC 2008 October 20.
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Discussion
Stabilization of RING-finger like domains
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The high resolution structures now available for U-box and RING-finger domains provide a
basis for analysis of other related domains. In particular, the comparison of residues now shown
to contribute to domain stabilization is highly informative. Consider, for example, the Mizfinger domain, which is related to U-box and RING-finger domains but is contained in proteins
(e.g. the Siz and PIAS families) that function as E3 ligases in SUMOlation as opposed to
ubiquitination pathways (40). Alignment of the U-box domain of Prp19, the RING-finger
domain of Rag1, and several Miz-finger domains provides tantalizing clues to the architecture
and structural basis for stabilization of the Miz-finger domain, the structure of which has not
been determined. This analysis strongly suggests that the Miz-finger has a unique composition
(Figure 4A). The Miz-finger domain likely contains a canonical RING-like stabilization center
(red) combined with a Prp19 U-box-like stabilization center (aqua) (Figure 4A). Thus, the Mizfinger domain is likely a hybrid U-box/RING-finger domain with N-terminal stabilization via
a network of hydrogen bonds and salt bridges, and C-terminal stabilization via zinc chelation
(Figure 4B). Since the Miz-finger domains are involved in SUMO-signaling, it is intriguing to
consider the biochemical and biological implications of the use of these distinct, yet
architecturally similar, domains in parallel cascades. In summary, the addition of the Prp19 Ubox to the collection of high resolution structures of RING-finger domains enhances the ability
to predict the molecular architecture of RING-finger/U-box-related domains.
Model of the Prp19 tetramer
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The determination of the structure of the U-box dimer enables construction of a complete model
for the intact Prp19 tetramer: a central tetrameric coiled-coil, with two U-box dimers and four
flexibly attached WD40 repeat domains (Figure 5A). E3 ligases require two essential functional
domains: an E2 recruiting domain (e.g. U-box) and a substrate recognition domain (e.g. WD40
repeat domain) (Figure 5B). It is commonly held that the mode of action of the E3 ligase is to
bring the E2 and substrate into close proximity, thereby catalyzing the transfer of the activated
ubiquitin (11, 41). Utilization of complex quaternary structure for positioning of the E2 and
substrate has been proposed to be a common feature of complex E3 ubiquitin ligases such as
BRCA1/BARD1 and the multicomponent SCF and APC ligases. For example, the βTrcP1 SCF
complex has been proposed to structurally enforce the precise structural positioning of E2 and
substrate required for catalysis through the spatial organization of the E2 recruiting RING
finger and the substrate recruiting WD40 repeats (11). In any single Prp19 polypeptide chain
(protomer), the U-box and WD40 repeat domains are spatially remote. The model of the
quaternary structure of Prp19 reveals the U-box domain from one Prp19 protomer is in fact in
close proximity to a WD40 repeat domain from one of the other protomers (Figure 5C). It is
likely that the molecular scaffold created by the Prp19 tetrameric architecture is important for
orienting the E2-recruiting U-box dimer with respect to both WD40 repeats and also to other
members of the NTC splicing complex (Figure 5C). Clearly, further structural analysis of Prp19
in complex with substrate and its E2 is required to elucidate the mechanism of action and extent
of coordination of the oligomer subunits.
A general architecture for dimerization?
While the number of characterized oligomeric E3 ubiquitin ligases continues to grow, it
remains to be seen if common architectures are utilized to orient both E2 and substrate
recruiting domains. Does the Prp19 U-box dimer reveal a common architecture for orienting
and positioning the E2 recruiting domain in an E3 ligase? Dimerization through RING-finger
domains in E3 ligases has been examined in two previous studies of Rag1 (39) and BRCA1/
BARD1 (21). Comparison of the topology of Prp19 (Figure 6A) with BRCA1 (Figure 6B) and
Rag1 (Figure 6C) is instructive. The Prp19 U-box and BRCA1 RING-finger dimers have
Biochemistry. Author manuscript; available in PMC 2008 October 20.
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conserved overall topologies with a similar interface (Figure 6A, B). In both cases, the dimer
interface is formed by the face of the three β-strands and additional residues from the Nterminus. Importantly, for BRCA1/BARD1 the dimer interface encompasses residues N- and
C-terminal to the RING-finger, which come together to form a four-helix bundle. The
formation of the stable four-helix bundle provides the driving force for dimerization, which in
turn results in steric constraints that orient the two RING-fingers. Thus, we believe the fourhelix bundle in BRCA1/BARD1 serves in a role similar to the four helix coiled-coil in the
Prp19 tetramer. In the case of the Rag1 homodimer, a helix from each subunit contributes to
the dimer interface, which orients the RING-finger domains in-trans with a separation of
∼15-20 Å. In all three cases, oligomerization positions the two U-box or RING-fingers in a
very similar relative orientation. Thus, it appears there is a common overall architecture
positioning the E2 recruiting domains in these U-box/RING-finger oligomeric E3 ligases.
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If our hypothesis is correct, this architecture should be present in a range of oligomeric E3
ligases. One such E3 ligase is Mdm2, an important regulator of p53 that belongs to the RINGfinger family of E3 ligases that has been shown to form RING-finger-mediated homodimers
and also heterodimers with MdmX (22,42). In fact, there are striking similarities between
Mdm2, MdmX and Prp19 with respect to conservation of the hydrophobic residues critical for
formation of the U-box dimer interface (Figure 6C): Mdm2 contains four long-chain
hydrophobic residues in these positions and in MdmX three of the four positions are also
hydrophobic residues. Thus, it is quite likely that Mdm2 and MdmX utilize a similar
dimerization interface and overall architecture as that found in Prp19.
Functional implications of U-box/RING-finger dimerization
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Many essential RING-finger and U-box domain proteins including Mdm2, MdmX, PML,
Parkin, Ufd2, and CHIP have been shown to form complex oligomeric E3 ligases (22-25,43).
Consequently, it is highly relevant to consider the possible functional implications of the
dimeric state of U-box/RING-finger domains. The potential for recruitment of multiple E2
enzymes carrying activated ubiquitin molecules is clearly very important. Prp19 has two
identical E2 binding surfaces on opposite sides of the tetramer and the U-box dimer structure
revealed that they are distinct from the dimer interface and therefore both accessible (9,19).
Heterodimerization may offer a means for functional spectificity, enabling the recruitment of
two different E2 enzymes. Indeed, BRCA1 has been shown to selectively recruit its E2, Ubc5,
in the context of the BRCA1/BARD1 heterodimer (44). The ability to recruit multiple and/or
different E2 enzymes may play a role in differentiating the type of ubiquitin-like modifications
catalyzed by multi-functional E3 ligases. Mdm2, for instance, has been shown to function in
either ubiquitin mediated signaling through recruitment of Ubc5, or in NEDD8 signaling
through recruitment of Ubc12 (45). In addition, the ability to recruit more than one E2 to the
site of ubiquitination may provide a means for the efficient formation of poly-ubiquitin chains
or for the formation of specific branched ubiquitin chains. For example, Ufd2 and CHIP, both
U-box domain proteins, can function independently in catalyzing the addition of short ubiquitin
chains to UNC-45, whereas the hetero-oligomer is able to rapidly and efficiently polyubiquitinate this substrate (43). Thus, the recruitment of multiple E2 enzymes may be critical
for the E4 ligase activity observed for Ufd2 (43,46,47).

Conclusions
The structure and characterization of the U-box dimer showed that oligomerization has
important implications for Prp19 function. The organization of Prp19, like other complex
ubiquitin ligase families, appears to be finely tuned to orient and align the E2 enzyme and
substrate for efficient ubiquitin transfer. Because multiple E2/substrate recruitment modules
exist in the Prp19 tetramer, a second consequence of Prp19's complex oligomeric architecture
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is the potential to couple targeting of substrates. Either positive coupling, where two or more
substrates are coordinately targeted, or negative coupling where either one or another target is
selectively or alternately targeted, can be envisioned. While further experiments are required
to test and refine these ideas, the potential for control through oligomerization provides an
interesting alternative means for directly regulating the ubiquitination of substrates.
Investigations along these lines should provide important new insights into the physical basis
for the activity of oligomeric E3 family ubiquitin ligases.

Acknowledgements
We thank Drs. Beth Vander Kooi, Joel Harp, Chris Rife, and Thomas Walz for valuable advice and technical expertise,
and Dr. Henry Bellamy for help in data collection.

Abbreviations
ubl, ubiquitin-like; RING, really interesting new gene; SCF, Skp1/Cullin/F-box; HECT,
homology to E6-AP c-terminus; AU, analytical ultracentrifugation.

References
NIH-PA Author Manuscript
NIH-PA Author Manuscript

1. Schwartz DC, Hochstrasser M. A superfamily of protein tags: ubiquitin, SUMO and related modifiers.
Trends Biochem Sci 2003;28:321–8. [PubMed: 12826404]
2. Huang DT, Walden H, Duda D, Schulman BA. Ubiquitin-like protein activation. Oncogene
2004;23:1958–71. [PubMed: 15021884]
3. Hochstrasser M. Ubiquitin and intracellular protein degradation. Curr Opin Cell Biol 1992;4:1024–
31. [PubMed: 1336669]
4. Thrower JS, Hoffman L, Rechsteiner M, Pickart CM. Recognition of the polyubiquitin proteolytic
signal. Embo J 2000;19:94–102. [PubMed: 10619848]
5. Pickart CM. Ubiquitin enters the new millennium. Mol Cell 2001;8:499–504. [PubMed: 11583613]
6. Aguilar RC, Wendland B. Ubiquitin: not just for proteasomes anymore. Curr Opin Cell Biol
2003;15:184–90. [PubMed: 12648674]
7. Haglund K, Di Fiore PP, Dikic I. Distinct monoubiquitin signals in receptor endocytosis. Trends
Biochem Sci 2003;28:598–603. [PubMed: 14607090]
8. Walden H, Podgorski MS, Schulman BA. Insights into the ubiquitin transfer cascade from the structure
of the activating enzyme for NEDD8. Nature 2003;422:330–4. [PubMed: 12646924]
9. Zheng N, Wang P, Jeffrey PD, Pavletich NP. Structure of a c-Cbl-UbcH7 complex: RING domain
function in ubiquitin-protein ligases. Cell 2000;102:533–9. [PubMed: 10966114]
10. Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem 2001;70:503–33. [PubMed:
11395416]
11. Wu G, Xu G, Schulman BA, Jeffrey PD, Harper JW, Pavletich NP. Structure of a beta-TrCP1-Skp1beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1)
ubiquitin ligase. Mol Cell 2003;11:1445–56. [PubMed: 12820959]
12. Freemont PS. RING for destruction? Curr Biol 2000;10:R84–7. [PubMed: 10662664]
13. Joazeiro CA, Weissman AM. RING finger proteins: mediators of ubiquitin ligase activity. Cell
2000;102:549–52. [PubMed: 11007473]
14. Aravind L, Koonin EV. The U box is a modified RING finger - a common domain in ubiquitination.
Curr Biol 2000;10:R132–4. [PubMed: 10704423]
15. Hatakeyama S, Yada M, Matsumoto M, Ishida N, Nakayama KI. U box proteins as a new family of
ubiquitin-protein ligases. J Biol Chem 2001;276:33111–20. [PubMed: 11435423]
16. Patterson C. A new gun in town: the U box is a ubiquitin ligase domain. Sci STKE 2002;2002:PE4.
[PubMed: 11805346]
17. Cyr DM, Hohfeld J, Patterson C. Protein quality control: U-box-containing E3 ubiquitin ligases join
the fold. Trends Biochem Sci 2002;27:368–75. [PubMed: 12114026]

Biochemistry. Author manuscript; available in PMC 2008 October 20.

Vander Kooi et al.

Page 10

NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript

18. Hatakeyama S, Nakayama KI. U-box proteins as a new family of ubiquitin ligases. Biochem Biophys
Res Commun 2003;302:635–45. [PubMed: 12646216]
19. Ohi MD, Vander Kooi CW, Rosenberg JA, Chazin WJ, Gould KL. Structural insights into the U-box,
a domain associated with multi-ubiquitination. Nat Struct Biol 2003;10:250–5. [PubMed: 12627222]
20. Andersen P, Kragelund BB, Olsen AN, Larsen FH, Chua NH, Poulsen FM, Skriver K. Structure and
biochemical function of a prototypical arabidopsis U-box domain. J Biol Chem. 2004
21. Brzovic PS, Rajagopal P, Hoyt DW, King MC, Klevit RE. Structure of a BRCA1-BARD1
heterodimeric RING-RING complex. Nat Struct Biol 2001;8:833–7. [PubMed: 11573085]
22. Tanimura S, Ohtsuka S, Mitsui K, Shirouzu K, Yoshimura A, Ohtsubo M. MDM2 interacts with
MDMX through their RING finger domains. FEBS Lett 1999;447:5–9. [PubMed: 10218570]
23. Wei X, Yu ZK, Ramalingam A, Grossman SR, Yu JH, Bloch DB, Maki CG. Physical and functional
interactions between PML and MDM2. J Biol Chem 2003;278:29288–97. [PubMed: 12759344]
24. Imai Y, Soda M, Hatakeyama S, Akagi T, Hashikawa T, Nakayama KI, Takahashi R. CHIP is
associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin
ligase activity. Mol Cell 2002;10:55–67. [PubMed: 12150907]
25. Nikolay R, Wiederkehr T, Rist W, Kramer G, Mayer MP, Bukau B. Dimerization of the human E3
ligase CHIP via a coiled-coil domain is essential for its activity. J Biol Chem 2004;279:2673–8.
[PubMed: 14610072]
26. Guthrie, C.; Fink, GR. Academic Press, Inc.; San Diego, CA: 1991.
27. Gietz RD, Schiestl RH, Willems AR, Woods RA. Studies on the transformation of intact yeast cells
by the LiAc/SS-DNA/PEG procedure. Yeast 1995;11:355–60. [PubMed: 7785336]
28. Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation
and lamm equation modeling. Biophys J 2000;78:1606–19. [PubMed: 10692345]
29. Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode.
Macromolecular Crystallography 1997;276(Pt A):307–326.
30. Terwilliger TC. SOLVE and RESOLVE: automated structure solution and density modification.
Methods Enzymol 2003;374:22–37. [PubMed: 14696367]
31. Terwilliger T. SOLVE and RESOLVE: automated structure solution, density modification and model
building. J Synchrotron Radiat 2004;11:49–52. [PubMed: 14646132]
32. McRee DE. XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron
density. J Struct Biol 1999;125:156–65. [PubMed: 10222271]
33. Murshudov GN. Refinement of macromolecular structures by the maximum-likelihood method. Acta
Crystallogr D Biol Crystallogr 1997;53:240–55. [PubMed: 15299926]
34. Ohi MD, Vander Kooi CW, Rosenberg JA, Ren L, Hirsch JP, Chazin WJ, Walz T, Gould KL.
Structural and Functional Analysis of Essential pre-mRNA Splicing Factor Prp19p. Mol Cell Biol
2005;25:451–60. [PubMed: 15601865]
35. Mer G, Bochkarev A, Gupta R, Bochkareva E, Frappier L, Ingles CJ, Edwards AM, Chazin WJ.
Structural basis for the recognition of DNA repair proteins UNG2, XPA, and RAD52 by replication
factor RPA. Cell 2000;103:449–56. [PubMed: 11081631]
36. Christodoulou J, Larsson G, Fucini P, Connell SR, Pertinhez TA, Hanson CL, Redfield C, Nierhaus
KH, Robinson CV, Schleucher J, Dobson CM. Heteronuclear NMR investigations of dynamic
regions of intact Escherichia coli ribosomes. Proc Natl Acad Sci U S A 2004;101:10949–54.
[PubMed: 15263071]
37. Revers LF, Cardone JM, Bonatto D, Saffi J, Grey M, Feldmann H, Brendel M, Henriques JA.
Thermoconditional modulation of the pleiotropic sensitivity phenotype by the Saccharomyces
cerevisiae PRP19 mutant allele pso4-1. Nucleic Acids Res 2002;30:4993–5003. [PubMed:
12434004]
38. Lawrence MC, Colman PM. Shape complementarity at protein/protein interfaces. J Mol Biol
1993;234:946–50. [PubMed: 8263940]
39. Bellon SF, Rodgers KK, Schatz DG, Coleman JE, Steitz TA. Crystal structure of the RAG1
dimerization domain reveals multiple zinc-binding motifs including a novel zinc binuclear cluster.
Nat Struct Biol 1997;4:586–91. [PubMed: 9228952]

Biochemistry. Author manuscript; available in PMC 2008 October 20.

Vander Kooi et al.

Page 11

NIH-PA Author Manuscript
NIH-PA Author Manuscript

40. Hochstrasser M. SP-RING for SUMO: new functions bloom for a ubiquitin-like protein. Cell
2001;107:5–8. [PubMed: 11595179]
41. VanDemark AP, Hill CP. Structural basis of ubiquitylation. Curr Opin Struct Biol 2002;12:822–30.
[PubMed: 12504688]
42. Sharp DA, Kratowicz SA, Sank MJ, George DL. Stabilization of the MDM2 oncoprotein by
interaction with the structurally related MDMX protein. J Biol Chem 1999;274:38189–96. [PubMed:
10608892]
43. Hoppe T, Cassata G, Barral JM, Springer W, Hutagalung AH, Epstein HF, Baumeister R. Regulation
of the Myosin-Directed Chaperone UNC-45 by a Novel E3/E4-Multiubiquitylation Complex in C.
elegans. Cell 2004;118:337–49. [PubMed: 15294159]
44. Brzovic PS, Keeffe JR, Nishikawa H, Miyamoto K, Fox D 3rd, Fukuda M, Ohta T, Klevit R. Binding
and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proc Natl
Acad Sci U S A 2003;100:5646–51. [PubMed: 12732733]
45. Xirodimas DP, Saville MK, Bourdon JC, Hay RT, Lane DP. Mdm2-mediated NEDD8 conjugation
of p53 inhibits its transcriptional activity. Cell 2004;118:83–97. [PubMed: 15242646]
46. Koegl M, Hoppe T, Schlenker S, Ulrich HD, Mayer TU, Jentsch S. A novel ubiquitination factor, E4,
is involved in multiubiquitin chain assembly. Cell 1999;96:635–44. [PubMed: 10089879]
47. Richly H, Rape M, Braun S, Rumpf S, Hoege C, Jentsch S. A series of ubiquitin binding factors
connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting. Cell 2005;120:73–
84. [PubMed: 15652483]
48. Koradi R, Billeter M, Wuthrich K. MOLMOL: a program for display and analysis of macromolecular
structures. J. Mol. Graphics 1996;14:51–55.
49. Pickles LM, Roe SM, Hemingway EJ, Stifani S, Pearl LH. Crystal structure of the C-terminal WD40
repeat domain of the human Groucho/TLE1 transcriptional corepressor. Structure (Camb)
2002;10:751–61. [PubMed: 12057191]

NIH-PA Author Manuscript
Biochemistry. Author manuscript; available in PMC 2008 October 20.

Vander Kooi et al.

Page 12

NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript

Figure 1.

The U-box domain of Prp19 exists as a functional dimer. A) Prp19 contains three domains: an
N-terminal U-box, a central tetrameric coiled-coil, and a C-terminal WD-40 repeat domain.
B) Analytical ultracetrifugation reveals that the coiled-coil domain drives the formation of a
single functional tetramer in the context of a construct containing both U-box and coiled-coil
domains. C) The construct containing U-box and coiled-coil domains is well structured with
primarily helical content. D) NMR reveals that the U-box domain is integrally connected to
Prp19 and not flexibly linked, as is the case for the C-terminal WD40 repeats. E) The U-box
of Prp19 exists in a monomer/dimer equilibrium. F) A model of the U-box and coiled-coil
regions of Prp19 showing the symmetric U-box dimers formed around the coiled-coil tetramer.
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Figure 2.

Basis for Prp19 dimerization A) Ribbon diagram of the Prp19 U-box dimer. Molecular graphics
were generated using MOLMOL (48). B) Prp19 contains a central hydrophobic patch at the
dimer interface composed of four long-chain hydrophobic residues, shown with a zoom
showing the electron density at the dimer interface. C) Representative 2FO-FC electron density
map of the dimer interface contoured at 2σ (generated with PYMOL; http://www.pymol.org).
D) Mutation of the central hydrophobic L15 to glutamate disrupts the ability of the U-box to
dimerize. AU profile of Prp19(1-73) L15E shows only one peak with a sedimentation
coeffiecient consistent with the monomeric species. E) 15N-1H HSQC of the same construct
shows excellent line width and chemical shift dispersion, characteristics of a well folded
domain. Additionally, the chemical shifts are virtually superimposable with the wild-type
protein (19) demonstrating that the L15E mutation causes minimal structural perturbation and
adopts a native-like structure. F) Mutations to the residues in the dimer interface abrogate Prp19
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function in vivo either in rescuing a temperature sensitive strain (Upper panel) or rescuing
growth for the null allele (Lower panel).
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Figure 3.
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Stabilization centers of the U-box domain. A) U-box domain is stabilized by two networks of
hydrogen bonds and salt bridges in Prp19. B) In contrast the RING-finger domain of Rag1
(1RMD) is stabilized by chelation of two zinc atoms. C, D) The C-terminal stabilization center
of Prp19 is much more compact and largely recapitulates the organization of the RING-finger
center (D), but with Asp38 extended to occupy the position of the central zinc atom. E) The
N-terminal stabilization center of the U-box contains an extended network of inter-residue
interactions including many between side chain and main chain amides. Distances between
potential hydrogen bond donors and acceptors are color coded: d < 3.0Å as green, 3.0< d <3.25
as pink, 3.25< d <3.50 as tan. F) The zinc mediated RING-finger contains the four zinc-sulfur
bonds.
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Figure 4.

Comparison of related E3 ligase domain stabilization A) Multiple sequence alignment of
Prp19, Rag1, and three human Miz-finger domains. Residues contributing to the N-terminal
center of the U-box are highlighted in blue. Residues contributing to the C-terminal center of
the RING-finger domain are highlighted in red. B) Schematic of the cross-braced stabilization
of U-box and RING-finger proteins with hydrogen-bonding and zinc centers in cyan and red,
respectively. Both domains contain a core helix (large rectangle) and three short β-strands
(small rectangles). The cross-brace is mediated through the central strand, represented by the
dotted line connecting the two stabilization centers. The Miz-finger domain found in related
SUMO E3 ligases appears to represent a hybrid of these domains.
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Figure 5.
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Model of the quaternary structure of Prp19. A) Prp19 exists as a functional tetramer with
dimeric U-box domains and flexibly attached WD40 domains. WD40 repeat domain modeled
from Groucho/Tle1 (49). B) The basic domain structure of an E3 ligase requires E2 and
substrate recruitment domains. C) The quaternary structure of Prp19 suggests a common
architecture for oligomeric E3 ubiquitin ligases that brings the E2 recruitment domain into
close proximity with a substrate recognition domain.
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Figure 6.

The Prp19 dimer as a general model for oligomeric E3 ligases. Comparison of the dimerization
interfaces of A) Prp19 B) BRCA1/BARD1 (1JM7) and C) Rag1 (1RMD), respectively, show
different characterized dimerization interfaces. The U-box or RING-finger dimerization
interface appears structurally conserved between Prp19 and BRCA1 D) Multiple sequence
alignment of dimeric RING-finger domains of Mdm2 and MdmX with Prp19. The four
hydrophobic residues at the Prp19 dimer interface are highlighted.

NIH-PA Author Manuscript
Biochemistry. Author manuscript; available in PMC 2008 October 20.

Vander Kooi et al.

Page 19

Table 1

Crystal and Refinement Statistics for the Prp19 U-box Dimer
Native
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Beamline
Space group
Wavelength (Å)
Unit-cell parameters
a (Å)
b (Å)
c (Å)
Unique reflections
Completeness (%)
Resolution (Å)
Rmerge (%)
Redundancy
I/σ (I)
Resolution Limits (Å)
Number of reflections
used in refinement
Number of reflections
used to compute Rfree
R (Rfree)
# protein atoms
# solvent molecules

PDX
P212121
1.381
49.421
57.105
122.587
52742
93.3 (85.6)
1.50 (1.55-1.50)
6.3 (42.9)
7.5 (6.5)
38.7 (3.1)
22.93-1.50
49928
2632
18.2 (20.4)
2758
387

SeMet
Edge
PDX
P212121
0.979653
49.038
56.558
122.420
22973
99.9 (100.0)
2.50 (2.59-2.50)
7.6 (39.8)
4.5 (4.2)
14.0 (3.2)

Peak

Remote

0.979344

0.92526

23144
99.9 (100.0)
2.50 (2.59-2.50)
7.7 (40.1)
4.5 (4.4)
13.3 (3.1)
Ramachandran
Most Favored
Additionally allowed
Generously
Dissallowed

23461
99.8 (100.0)
2.50 (2.59-2.50)
7.0(34.8)
4.2 (4.0)
13.4 (3.8)

RMS deviations
Bond, Å
Angle, °
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91.8
8.2
0.0
0.0

0.012
1.5

